作者：
Yuki,Shimizu [1]
;
Kohei,Maruyama [1]
;
Mai,Suzuki [1]
;
Hiroshi,Kawachi [2]
;
Siew-Kee,Low [3]
;
Tomoko,Oh-Hara [4]
;
Kengo,Takeuchi [5]
;
Naoya,Fujita [6]
;
Satoshi,Nagayama [7]
;
Ryohei,Katayama [8]
作者单位：
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
[1]
Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
[2]
Cancer Precision Medicine Center, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
[3]
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
[4]
Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Pathology Project for Molecular Targets, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
[5]
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
[6]
Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Surgery, Uji-Tokushukai Medical Center, Kyoto, Japan.
[7]
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan. Electronic address: ryohei.katayama@jfcr.or.jp.
[8]
DOI
10.1016/j.canlet.2022.215799
PMID
35724767
发布时间
2022-08-17
换一批
换一批
